Showing results (681-690 of 938) with videos related to

Sort By:
Pageof 94
Scientific Reports|May 13, 2022
Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillationTeresa Oliveras, Elena Revuelta-López, Cosme García-García, et al.
Transplantation|April 24, 2008
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter studyEsteban Porrini, Jose Manuel Moreno, Antonio Osuna, et al.
JAMA|December 29, 2005
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trialL Brent Mitchell, Derek V Exner, D George Wyse, et al.
JAMA|January 16, 2024
Default Palliative Care Consultation for Seriously Ill Hospitalized Patients: A Pragmatic Cluster Randomized TrialKatherine R Courtright, Vanessa Madden, Brian Bayes, et al.
European Journal of Heart Failure|June 16, 2023
Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trialAntoni Bayes-Genis, Josep Lupón, Elena Revuelta-Lopez, et al.
American Journal of Translational Research|June 18, 2014
Engineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived progenitor cells for cardiac regenerationCarolina Soler-Botija, Juli R Bagó, Aida Llucià-Valldeperas, et al.
Circulation|May 5, 2025
Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future DirectionsMarco Metra, Daniela Tomasoni, Marianna Adamo, et al.
Theranostics|July 14, 2022
Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine modelMarta Monguió-Tortajada, Cristina Prat-Vidal, Daina Martínez-Falguera, et al.
European Heart Journal|October 7, 2025
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure AssociationPablo Garcia-Pavia, Esther Gonzalez-Lopez, Lisa J Anderson, et al.
Scientific Reports|September 17, 2024
High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failureEnrique Santas, Sandra Villar, Patricia Palau, et al.
Pageof 94